HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Ohkita Selected Research

J 104132

2/2011Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation.
12/2009Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Ohkita Research Topics

Disease

28Ischemia
01/2019 - 04/2005
21Acute Kidney Injury (Acute Renal Failure)
01/2022 - 03/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2007
7Hypertension (High Blood Pressure)
01/2020 - 05/2005
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 09/2008
5Pulmonary Hypertension
01/2021 - 07/2009
5Reperfusion Injury
07/2013 - 08/2002
4Vascular Diseases (Vascular Disease)
11/2014 - 04/2005
4Necrosis
09/2005 - 08/2002
3Chronic Renal Insufficiency
01/2022 - 01/2009
3Right Ventricular Hypertrophy
01/2021 - 06/2018
3Metrorrhagia (Spotting)
02/2011 - 04/2007
2Hyperplasia
08/2019 - 12/2009
2Vascular Remodeling
01/2019 - 10/2012
2Proteinuria
01/2014 - 05/2008
2Wounds and Injuries (Trauma)
10/2012 - 07/2005
2Atherosclerosis
01/2012 - 01/2012
2Neointima
02/2011 - 12/2009
2Ventricular Remodeling
07/2009 - 05/2005
1Renovascular Hypertension (Goldblatt Syndrome)
01/2022
1Vascular Ring
01/2021
1Fistula
08/2019
1Disease Progression
06/2018
1Vascular System Injuries
11/2014
1Hypertrophy
01/2012
1Inflammation (Inflammations)
01/2011

Drug/Important Bio-Agent (IBA)

20Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019 - 04/2005
12Endothelin-1 (Endothelin 1)IBA
01/2012 - 08/2002
11Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 08/2002
9Endothelins (Endothelin)IBA
11/2014 - 06/2006
7SaltsIBA
01/2020 - 05/2005
6Superoxides (Superoxide)IBA
08/2019 - 12/2006
5Desoxycorticosterone Acetate (DOCA)FDA Link
01/2020 - 12/2006
4Nitric Oxide Synthase (NO Synthase)IBA
01/2020 - 07/2005
4AtrasentanIBA
07/2012 - 04/2007
3Soluble Guanylyl CyclaseIBA
01/2022 - 01/2009
3MonocrotalineIBA
01/2021 - 07/2009
3Desoxycorticosterone (Deoxycorticosterone)IBA
01/2020 - 12/2006
3Acetates (Acetic Acid Esters)FDA Link
01/2020 - 12/2006
3Malondialdehyde (Propanedial)IBA
01/2019 - 12/2011
3Estrogens (Estrogen)FDA Link
11/2014 - 09/2012
3Endothelin-Converting EnzymesIBA
05/2011 - 09/2008
3Carboxylic AcidsIBA
02/2011 - 09/2008
3flavangenolIBA
01/2011 - 09/2005
2IndicanIBA
01/2022 - 01/2021
2NitratesIBA
01/2021 - 01/2019
2Thioctic Acid (Lipoic Acid)IBA
08/2019 - 03/2002
2NADPH Oxidases (NAD(P)H oxidase)IBA
08/2019 - 12/2006
2Messenger RNA (mRNA)IBA
08/2019 - 08/2002
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2019 - 12/2011
22- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA
01/2019 - 12/2011
2Angiotensin Receptor AntagonistsIBA
11/2014 - 05/2005
2moxonidine (Moxon)IBA
10/2013 - 01/2009
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2013 - 05/2008
2tempolIBA
07/2013 - 04/2005
2Pharmaceutical PreparationsIBA
01/2013 - 01/2009
2Estrogen ReceptorsIBA
01/2013 - 05/2012
2candesartanIBA
07/2012 - 05/2005
2gamma-Aminobutyric Acid (GABA)IBA
09/2011 - 11/2009
2GABA-B Receptor AntagonistsIBA
09/2011 - 11/2009
2GABA-B ReceptorsIBA
09/2011 - 11/2009
2benzocycloheptapyridineIBA
02/2011 - 12/2009
2AcidsIBA
02/2011 - 12/2009
2J 104132IBA
02/2011 - 12/2009
2AntioxidantsIBA
01/2011 - 03/2002
2NF-kappa B (NF-kB)IBA
09/2007 - 04/2005
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
01/2021
1neutrophil cytosol factor 67KIBA
08/2019
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
08/2019
1NitritesIBA
01/2019
1isosorbide-5-mononitrate (Ismo)FDA LinkGeneric
06/2018
1Monoamine Oxidase (MAO)IBA
01/2017
1Hydralazine (Apresoline)FDA LinkGeneric
01/2014
1efaroxanIBA
10/2013
1ImidazolinesIBA
10/2013
1TamoxifenFDA LinkGeneric
08/2013
1Hexamethonium (Hexamethonium Bromide)IBA
08/2013
11,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
1OligomycinsIBA
01/2013
1Adenosine Triphosphate (ATP)IBA
01/2013
1Aminobutyrates (Aminobutyric Acid)IBA
10/2012
1Type 1 Angiotensin ReceptorIBA
07/2012
1Endothelin Receptors (Endothelin Receptor)IBA
01/2012
1Biological ProductsIBA
01/2012
1Glutathione (Reduced Glutathione)IBA
12/2011
1Phosphinic Acids (Phosphinic Acid)IBA
09/2011
1Arginine (L-Arginine)FDA Link
05/2011
1A 192621IBA
12/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2009
1BaclofenFDA LinkGeneric
11/2009
1GABA-B Receptor AgonistsIBA
11/2009
1NK3201IBA
07/2009

Therapy/Procedure

13Nephrectomy
01/2014 - 07/2005
3Intravenous Injections
08/2013 - 11/2009
2Therapeutics
11/2014 - 05/2005
1Surgical Instruments (Clip)
01/2022
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
11/2014
1Ovariectomy (Oophorectomy)
02/2011
1Ischemic Postconditioning
01/2010